About Haystack Sciences
Haystack Sciences is a Healthcare company based in San Francisco (United States) founded in 2016 by Richard Edward Watts, and was acquired by Insitro in October 2020. Proprietary platform employed for small molecule drug discovery. Its chief executive, as recorded, is Richard Edward Watts. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.
Company details
Haystack Sciences was founded in 2016 in San Francisco, United States, as a small molecule drug discovery company. A proprietary platform is utilized to identify novel treatments for human diseases. Operations are conducted in stealth mode, with incubation provided by the Illumina Accelerator. The focus remains on advancing therapeutic development in the biotechnology sector.
- Headquarters San Francisco, United States
- Founders Richard Edward Watts
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website haystacksciences.com
- Acquired by Insitro (Oct 2020)
Funding Insights of Haystack Sciences
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Haystack Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2017 | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Haystack Sciences
Haystack Sciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Illumina and Insitro.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of technologies for analysis of genetic variation and function | 1993 | illumina.com | San Diego, United States | |
An AI-enabled platform is developed for infectious disease treatment. | 2018 | insitro.com | San Francisco, United States |
Investor details for Haystack Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Haystack Sciences
1 people are tracked at Haystack Sciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
Richard Edward Watts | Co-Founder & CEO | Leadership |
Complete people profiles for Haystack Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Haystack Sciences
3 dated milestones of Haystack Sciences across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Haystack Sciences is founded.
- Funding First funding round.
- Exit Acquired by Insitro.
Competitors of Haystack Sciences
Haystack Sciences has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed competitors of Haystack Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Haystack Sciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Haystack Sciences
Complete news archive for Haystack Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Haystack Sciences
Haystack Sciences was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Haystack Sciences is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Richard Edward Watts is the CEO of Haystack Sciences, as recorded in our data. They have also founded this company.
Haystack Sciences was founded in 2016 in San Francisco, United States, as a small molecule drug discovery company. A proprietary platform is utilized to identify novel treatments for human diseases. Operations are conducted in stealth mode, with incubation provided by the Illumina Accelerator. The focus remains on advancing therapeutic development in the biotechnology sector.
Haystack Sciences's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Yes. Haystack Sciences was acquired by Insitro in October 2020.